Ochre Bio
RNA medicines for liver diseases
Oxford, United Kingdom · Founded 2019
- Headquarters
- Oxford
- Employees
- 11–50
- Founded
- 2019
- Website
- ochre-bio.com
- Last Round
- Series AOct 2022
- Rounds
- 2
Indexed holds 2 funding rounds and 7 investors for this company. The full record is or through the API.
About
Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.
Summary
Ochre Bio is a Biotech company based in Oxford, United Kingdom, founded in 2019. Its most recent funding was a Series A round in Oct 2022. Investors include Khosla Ventures, Selvedge and Backed.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2022
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
China's leading blood products manufacturer
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ochre-bio"><img src="https://indexed.vc/api/badge/company/ochre-bio" alt="Ochre Bio on Indexed.vc" width="260" height="76" /></a>